Swisse is harnessing the power of a little-known plant called Andrographis paniculata to relieve symptoms of the common cold and provide immune support.
Post-operative gastrointestinal cancer patients may benefit from omega-3 polyunsaturated fatty acid emulsion as part of their parenteral nutrition formula, say researchers in China.
Chr. Hansen is optimistic it can tap into the benefits of its patented probiotic strain, LGG, and growing consumer health consciousness to drive sales in India.
Nestlé Japan has announced plans to branch out from the food and beverage business into healthcare, with personalised nutrition and aged care a prominent feature of this shift.
Industry needs to better strive for regulatory equivalence across Asia, and indeed globally, while also educating policymakers that the fast-paced industry can no longer be governed by rules that are 20 or 30 years old.
A US Supreme Court decision on a longstanding vitamin C price fixing case could further inflame trade tensions with China, an expert familiar with the case has said.
The latest insights into the health concerns driving supplement and functional food purchases across different age groups have been revealed at our first Healthy Ageing APAC Summit.
Asia Pacific’s rapidly ageing population will drive significant opportunities for the region’s food and nutrition industry, according to keynote speakers on day one of the inaugural event in Singapore.
Australian supplement firm Bod Australia will see George Livery — Swisse's former strategy and corporate director — join its ranks as executive chairman in September this year to drive the firm’s growth strategy in supplements and medical cannabis...
Researchers in Australia are continuing to explore the benefits of probiotics in relation to peanut allergy, buoyed by the findings of a follow-up study four years after their first published RCT.
Ongoing major acquisitions of Australian nutrition and supplement firms by Chinese investors have received a lukewarm response from the industry Down Under.
A NZ$13m research project will explore how sea lettuce, which is found in abundance at the Bay of Plenty, Tauranga in New Zealand, could be transformed into ingredients for supplements targeted at metabolic syndrome and heart health.
